Surgical Sealants and Adhesives Global Market – Forecast To 2024

Publishing Date : March, 2018
Report Code : HCMD0156
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Surgical sealants and adhesives are the products used to close the surgical incisions, post surgical application, block the passage of fluids through the surface or openings of the wounds and also to avoid the microbial adhesions and infections. Sealants and Adhesives are usually considered together as they both adhere and seal the surgical incisions. According to IQ4I analysis, the surgical sealants and adhesives global market is expected to grow at a strong CAGR to reach $3,708.5 million by 2024.

The surgical sealants and adhesives global market is mainly segmented by products, applications, end-users and by geography. The surgical sealants and adhesives global market by the product is segmented into natural and synthetic surgical sealants and adhesives. Natural surgical sealants and adhesives are segmented into fibrin, collagen, gelatin, albumin and others. Synthetic surgical sealants and adhesives are segmented into Cyanoacrylate, hydrogels and others. The application market is segmented into Cardiovascular surgery, General Surgery, Orthopaedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others applications. The end-users market is segmented into hospitals, ambulatory surgical centres and others.

Some of the major players in Surgical sealants and adhesives market include Baxter International Inc. (U.S.), Johnson & Johnson (Ethicon) (U.S.), Becton, Dickinson & Company (C.R.Bard) (U.S.), B.Braun Melsungen AG (Germany), Medtronic Plc (Ireland), Cryolife, Inc. (U.S.), Mallinckrodt Plc (U.K.), Advanced Medical Solutions Group Plc (U.K.), Takeda Pharmaceutical Company Ltd. (Japan), Cohera Medical, Inc. (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Others
  • Europe
  • Germany
  • U.K.
  • France
  • Others
  • Asia-Pacific 
  • Japan
  • China
  • India
  • Others
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East & Others
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASING DEMAND FOR SURGICAL PROCEDURES BOOSTS SURGICAL SEALANTS AND ADHESIVES MARKET GROWTH
        • 3.3.1.2     EMERGENCE OF TECHNICALLY ADVANCED PRODUCTS
        • 3.3.1.3     ACQUISITION TO OPEN AN ARRAY OF OPPORTUNITIES FOR THE MARKET TO FLOURISH
        • 3.3.1.4     INCREASING GERIATRIC POPULATION
        • 3.3.1.5     ACCEPTANCE OF SURGICAL SEALANTS AND ADHESIVES AND MARKET EXPANSION IN EMERGING NATIONS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     PITFALLS IN USAGE OF SURGICAL SEALANTS AND ADHESIVES
        • 3.3.2.2     EXPENSIVE SURGICAL SEALANTS AND ADHESIVES IMPEDING EFFECTIVE PENETRATION IN LOW AND MIDDLE INCOME COUNTRIES
        • 3.3.2.3     UNFAVORABLE REIMBURSEMENT POLICIES IN DEVELOPING NATIONS
        • 3.3.2.4     STRINGENT REGULATORY GUIDELINES
        • 3.3.2.5     AVAILABILITY OF ALTERNATIVE PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 14644-1 CLEAN ROOM STANDARDS
        • 3.4.1.3     ISO 13485 MEDICAL DEVICES
        • 3.4.1.4     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
      • 3.4.2     ASTM INTERNATIONAL STANDARDS
      • 3.4.3     U.S.
      • 3.4.4     CANADA
      • 3.4.5     EUROPE
      • 3.4.6     JAPAN
      • 3.4.7     CHINA
      • 3.4.8     INDIA
    • 3.5     CLINICAL TRIALS
    • 3.6     PORTER’S FIVE FORCE ANALYSIS
      • 3.6.1     THREAT OF NEW ENTRANTS
      • 3.6.2     THREAT OF SUBSTITUTES
      • 3.6.3     BARGAINING POWER OF SUPPLIERS
      • 3.6.4     BARGAINING POWER OF BUYERS
      • 3.6.5     RIVALRY AMONG EXISTING COMPETITORS
    • 3.7     SUPPLY CHAIN ANALYSIS
    • 3.8     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
    • 3.9     SURGICAL SEALANTS AND ADHESIVES COMPANY COMPARISON BY PRODUCT TYPE, MATERIAL, PRODUCT NAME AND APPLICATIONS
    • 3.10     MARKET PENETRATION OF SURGICAL SEALANTS AND ADHESIVES IN SURGICAL WOUND CLOSURE MARKET
  • 4     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     NATURAL SURGICAL SEALANTS AND ADHESIVES
      • 4.2.1     FIBRIN
      • 4.2.2     COLLAGEN
      • 4.2.3     GELATIN
      • 4.2.4     ALBUMIN
      • 4.2.5     OTHERS
    • 4.3     SYNTHETIC SURGICAL SEALANTS AND ADHESIVES
      • 4.3.1     CYANOACRYLATE
      • 4.3.2     HYDROGEL
      • 4.3.3     OTHERS
  • 5     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     CARDIOVASCULAR SURGERY
    • 5.3     GENERAL SURGERY
    • 5.4     ORTHOPAEDIC SURGERY
    • 5.5     UROLOGY
    • 5.6     PULMONOLOGY
    • 5.7     NEUROSURGERY
    • 5.8     GYNAECOLOGY
    • 5.9     COSMETIC SURGERY
    • 5.10     OTHERS
  • 6     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     AMBULATORY SURGICAL CENTERS
    • 6.4     OTHERS
  • 7     REGIONAL ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     U.K.
      • 7.3.3     FRANCE
      • 7.3.4     OTHERS
    • 7.4     APAC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     OTHERS
    • 7.5     ROW
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     APPROVALS
    • 8.3     AGREEMENT
    • 8.4     ACQUISITIONS
    • 8.5     NEW PRODUCT LAUNCH
    • 8.6     OTHER DEVELOPMENTS
  • 9     MAJOR COMPANIES
    • 9.1     ADVANCED MEDICAL SOLUTIONS GROUP PLC
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     BAXTER INTERNATIONAL, INC
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     B.BRAUN MELSUNGEN AG
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     BECTON, DICKINSON AND COMPANY (C.R.BARD INC.)
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS*
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     COHERA MEDICAL, INC.
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     CRYOLIFE, INC.
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     JOHNSON & JOHNSON (ETHICON)
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     MALLINCKRODT PLC
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     MEDTRONIC PLC
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     TAKEDA PHARMACEUTICAL COMPANY LTD.
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 2     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 3     NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 4     NATURALSURGICALSEALANTSANDADHESIVESGLOBALMARKETREVENUE, BYREGION, (2016-2024)($MN)
      • TABLE 5     FIBRIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 6     COLLAGEN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 7     GELATIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 8     ALBUMIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 9     OTHERNATURALSURGICALSEALANTSANDADHESIVESGLOBALMARKETREVENUE,BYREGION,(2016-2024)($MN)
      • TABLE 10     SYNTHETICSURGICALSEALANTSANDADHESIVESGLOBALMARKETREVENUE,BYPRODUCT,(2016-2024)($MN)
      • TABLE 11     SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 12     CYANOACRYLATE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 13     HYDROGEL GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 14     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 15     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 16     CARDIOVASCULAR SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 17     GENERAL SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 18     ORTHOPAEDIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 19     UROLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 20     PULMONOLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 21     NEUROSURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 22     GYNAECOLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 23     COSMETIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 24     OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 25     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
      • TABLE 26     HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 27     AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 28     OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 29     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 30     NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 31     NORTH AMERICA NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 32     NORTH AMERICA SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 33     NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 34     NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
      • TABLE 35     NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 36     EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 37     EUROPE NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 38     EUROPE SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 39     EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 40     EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
      • TABLE 41     EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 42     APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 43     APAC NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 44     APAC SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 45     APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 46     APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
      • TABLE 47     APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 48     ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
      • TABLE 49     ROW NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 50     ROW SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
      • TABLE 51     ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
      • TABLE 52     ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
      • TABLE 53     ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 54     APPROVALS (2015 - 2018)
      • TABLE 55     AGREEMENT (2015 - 2018)
      • TABLE 56     ACQUISITIONS (2015 - 2018)
      • TABLE 57     NEW PRODUCT LAUNCH (2015 - 2018)
      • TABLE 58     OTHER DEVELOPMENTS (2015 - 2018)
      • TABLE 59     ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 60     ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 61     ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 62     BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 63     BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 64     BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 65     B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 66     B.BRAUN MELSENGEN AG: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 67     B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 68     C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 69     C.R.BARD INC: TOTAL REVENUE BY SEGMENTS, (2015-17) ($MN)
      • TABLE 70     C.R. BARD: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 71     CRYOLIFE, INC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 72     CRYOLIFE, INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 73     CRYOLIFE, INC: TOTAL REVENUE, BY PRODUCTS, (2015-2017) ($MN)
      • TABLE 74     CRYOLIFE, INC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 75     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 76     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 77     JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICES SEGMENTS, (2015-2017) ($MN)
      • TABLE 78     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 79     MALLINCKRODT PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 80     MALLINCKRODT PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 81     MALLINCKRODT PLC: TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN)
      • TABLE 82     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 83     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 84     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 85     TAKEDA PHARMACEUTICAL COMPANY LTD: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)

      LIST OF FIGURES

      • FIGURE 1     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET
      • FIGURE 3     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 11     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET PENETRATION, BY APPLICATION (2017) (%)
      • FIGURE 12     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2016 - 2024) ($MN)
      • FIGURE 13     NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 14     NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 15     FIBRIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 16     COLLAGEN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 17     GELATIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 18     ALBUMIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 19     OTHER NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 20     SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 21     SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 22     CYANOACRYLATE GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 23     HYDROGEL GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 24     OTHERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 25     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY APPLICATION, (2017 V/S 2024) ($MN)
      • FIGURE 26     CARDIOVASCULAR SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 27     GENERAL SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 28     ORTHOPAEDIC SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 29     UROLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 30     PULMONOLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 31     NEUROSURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 32     GYNAECOLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 33     COSMETIC SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 34     OTHER APPLICATIONS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 35     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY END-USERS, (2017 V/S 2024) ($MN)
      • FIGURE 36     HOSPITALS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 37     AMBULATORY SURGICAL CENTERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 38     OTHER END-USERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
      • FIGURE 39     SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN), CAGR (%)
      • FIGURE 40     NORTH AMERICA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 41     NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 42     U.S. SURGICAL S & A MARKET REVENUE, BY PRODUCT/END-USER, NATURAL AND SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 43     U.S. SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 44     OTHER NORTH AMERICA COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 45     OTHER NORTH AMERICA COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 46     EUROPE SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 47     EUROPE SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 48     GERMANY SURGICAL S & A REVENUE, BY PRODUCT/END-USER NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 49     GERMANY SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 50     U.K. SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 51     U.K. SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 52     FRANCE SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 53     FRANCE SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 54     OTHER EUROPE COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 55     OTHER EUROPE COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 56     APAC SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 57     APAC SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 58     JAPAN SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 59     JAPAN SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 60     CHINA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 61     CHINA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 62     INDIA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 63     INDIA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 64     OTHER APAC COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 65     OTHER APAC COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 66     ROW SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 67     ROW SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 68     BRAZIL SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 69     BRAZIL SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 70     REST OF LATIN AMERICA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 71     REST OF LATIN AMERICA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 72     MIDDLE EAST AND OTHER ROW COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
      • FIGURE 73     MIDDLE EAST AND OTHER ROW COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
      • FIGURE 74     KEY GROWTH STRATEGIES, (2015-2018)
      • FIGURE 75     SWOT: ADVANCED SOLUTIONS GROUP PLC
      • FIGURE 76     SWOT: BAXTER INTERNATIONAL, INC.
      • FIGURE 77     SWOT: B.BRAUN MELSUNGEN, AG
      • FIGURE 78     SWOT: BD (C.R.BARD, INC.)
      • FIGURE 79     SWOT: COHERA MEDICAL, INC.
      • FIGURE 80     SWOT: CRYOLIFE, INC.
      • FIGURE 81     SWOT: JOHNSON & JOHNSON (ETHICON)
      • FIGURE 82     SWOT: MALLINCKRODT PLC
      • FIGURE 83     SWOT: MEDTRONIC, PLC
      • FIGURE 84     SWOT: TAKEDA PHARMACEUTICAL COMPANY LTD.

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ADHEZION BIOMEDICAL, LLC.
      • 2     ADVANCED MEDICAL SOLUTIONS GROUP PLC
      • 3     ARCH THERAPEUTICS, INC
      • 4     B.BRAUN MELSUNGEN AG
      • 5     BAXTER INTERNATIONAL, INC.
      • 6     BD (C.R. BARD, INC.)
      • 7     BEAVER VISITEC INTERNATIONAL
      • 8     CARDINALHEALTH, INC
      • 9     CHEMENCE MEDICAL, INC.
      • 10     COHERA MEDICAL, INC.
      • 11     CONNEXICON MEDICAL LTD.
      • 12     CRYOLIFE, INC.
      • 13     DYNASIL CORPORATION OF AMERICA (XCEDE TECHNOLOGIES, INC.)
      • 14     GECKO BIOMEDICAL
      • 15     GEM SRL
      • 16     GLUSTITCH, INC.
      • 17     GRÜNENTHAL GMBH (ADHESYS MEDICAL GMBH)
      • 18     HAGER & WERKEN GMBH & CO. KG
      • 19     H.B. FULLER
      • 20     HALYARD HEALTH, INC.
      • 21     HUALAN BIOLOGICAL ENGINEERING
      • 22     HYPERBRANCH MEDICAL TECHNOLOGY, INC.
      • 23     IBC PHARMACEUTICALS LTD.
      • 24     INTEGRA LIFESCIENCES HOLDINGS CORPORATION
      • 25     JOHNSON & JOHNSON (ETHICON )
      • 26     KUROS BIOSCIENCES AG
      • 27     LIFEBOND LTD.
      • 28     MALLINCKRODT PLC
      • 29     MEDTRONIC PLC
      • 30     OCULAR THERAPEUTIX, INC.
      • 31     OPTMED, INC.
      • 32     RELIANCE LIFE SCIENCE
      • 33     SEALANTIS LTD
      • 34     STARCH MEDICAL, INC.
      • 35     STRYKER CORPORATION
      • 36     SURGICAL SPECIALTIES CORPORATION
      • 37     TAKEDA PHARMACEUTICAL COMPANY LTD.
      • 38     TISSUEMED LTD.
      • 39     VIVOSTAT A/S
      • 40     WESTERN BIOMEDICAL